MLTX
MoonLake Immunotherapeutics
NASDAQ: MLTX · HEALTHCARE · BIOTECHNOLOGY
$16.38
+1.68% today
Updated 2026-04-30
Market cap
$1.23B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.53
Dividend yield
—
52W range
$6 – $63
Volume
1.1M
MoonLake Immunotherapeutics (MLTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-60.80%
ROA
-33.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-90838.00 | — | — | — |
| 2021 | — | $-4.54M | — | — | — |
| 2022 | $0.00 | $-64.51M | — | — | — |
| 2023 | $0.00 | $-36.01M | — | — | — |
| 2024 | $0.00 | $-118.94M | — | — | — |
| 2025 | $0.00 | $-227.32M | — | — | — |